By Inkyu Oh | Uihak Shinmun / Ilgan Bosa | Updated March 21, 2026 

Ultrasound medical device specialist Newpong is presenting its full ultrasound technology portfolio, spanning aesthetics, surgery, and therapy, at Booth A713 during KIMES 2026 (Korea International Medical & Hospital Equipment Show). 

The centerpiece of the exhibition is Lincurve, a home HIFU device scheduled for official launch in May and Newpong's first B2C product. Lincurve extends the clinical ultrasound technology developed through the company's hospital-grade device line into the consumer home care market. 

Built on the Concave Technology™ design philosophy used in the clinical Lincurve Pro, Lincurve is engineered to deliver clinic-level lifting results at home. Unlike conventional home beauty devices designed for daily use, Lincurve proposes a usage protocol more akin to clinical practice: one intensive session per month, supplemented by a maintenance session once a week. This structured regimen meaningfully differentiates its positioning in the consumer market. 

 Lincurve

Newpong is also presenting its clinical ultrasound medical device lineup at the exhibition, which serves as the technological foundation behind the company’s expanding ultrasound ecosystem. At the center of the lineup is Lincurve Pro, the world’s first HIFU system incorporating Newpong’s patented Concave Technology™. Unlike conventional flat cartridges, its curved design naturally conforms to the contours of the skin, enabling more uniform and precise ultrasound energy delivery.

As a next-generation lifting solution designed to enhance both procedural efficiency and safety, Lincurve Pro has been attracting strong interest in clinical practice settings.

Also featured is LSSA, a minimally invasive ultrasound-assisted lipolysis system equipped with an ultra-thin 0.9 mm probe. Powered by Newpong’s proprietary ultrasound control algorithm, the device delivers stable energy transmission and precise fat fragmentation. LSSA continues to expand its applications across both aesthetic and surgical procedures, and will be introduced at the exhibition alongside detailed clinical data.

In the therapeutic segment, SonoCare is designed for pain relief and tissue regeneration, and has established clinical efficacy in rehabilitation medicine and physical therapy.  

 (from left) LSSA, Lincurve Pro, Sonocare

The company explained that the launch of Lincurve was strategically designed to create synergy with its existing clinical business, emphasizing that its entry into the home-care market is expected to generate new consumer demand rather than cannibalize B2B channels.

A Newpong representative stated, “Newpong has grown as a company centered on clinical ultrasound medical devices, and with the launch of Lincurve, we plan to accelerate our expansion into the B2C home-care market. Leveraging the ultrasound technologies refined in medical settings, we aim to introduce a new ultrasound aesthetic category that connects clinical care with home care.”

Detailed product information and technical specifications for Lincurve are available on the official website, and visitors will be able to experience the device firsthand at Booth A713 during KIMES 2026.